Orion Portfolio Solutions LLC reduced its stake in The Cigna Group (NYSE:CI - Free Report) by 6.0% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 39,733 shares of the health services provider's stock after selling 2,557 shares during the quarter. Orion Portfolio Solutions LLC's holdings in The Cigna Group were worth $13,765,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CI. TruNorth Capital Management LLC bought a new position in The Cigna Group in the 2nd quarter worth approximately $33,000. Ulland Investment Advisors LLC increased its position in The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider's stock worth $36,000 after buying an additional 100 shares during the period. Prospera Private Wealth LLC bought a new position in The Cigna Group in the 3rd quarter worth approximately $37,000. Harbor Capital Advisors Inc. bought a new position in The Cigna Group in the 3rd quarter worth approximately $45,000. Finally, Private Ocean LLC increased its position in The Cigna Group by 29.9% in the 2nd quarter. Private Ocean LLC now owns 200 shares of the health services provider's stock worth $66,000 after buying an additional 46 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.
The Cigna Group Price Performance
CI traded down $4.80 during trading on Friday, hitting $317.81. The company's stock had a trading volume of 1,745,956 shares, compared to its average volume of 1,560,104. The firm's 50 day moving average price is $331.01 and its two-hundred day moving average price is $338.05. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a 12 month low of $253.95 and a 12 month high of $370.83. The stock has a market capitalization of $88.40 billion, a price-to-earnings ratio of 29.98, a price-to-earnings-growth ratio of 0.99 and a beta of 0.50.
The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. During the same period in the prior year, the company posted $6.77 EPS. The company's revenue was up 29.8% compared to the same quarter last year. Sell-side analysts forecast that The Cigna Group will post 28.49 earnings per share for the current fiscal year.
The Cigna Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th will be given a dividend of $1.40 per share. The ex-dividend date of this dividend is Wednesday, December 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.76%. The Cigna Group's payout ratio is currently 52.83%.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on CI. JPMorgan Chase & Co. raised their target price on The Cigna Group from $435.00 to $438.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 21st. StockNews.com cut The Cigna Group from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $400.00 target price on shares of The Cigna Group in a research report on Wednesday, October 23rd. Stephens reaffirmed an "overweight" rating and issued a $410.00 target price on shares of The Cigna Group in a research report on Friday, November 1st. Finally, Barclays raised their target price on The Cigna Group from $405.00 to $420.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 5th. One research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $394.64.
Check Out Our Latest Stock Report on The Cigna Group
The Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.